Clovis Oncology Inc EBIT margin
Was ist das EBIT margin von Clovis Oncology Inc?
EBIT margin von Clovis Oncology Inc ist -161.75%
Was ist die Definition von EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Clovis Oncology Inc
Unternehmen mit ebit margin ähnlich Clovis Oncology Inc
- W Resources Plc hat EBIT margin von -164.36%
- Haydale Graphene Industries plc hat EBIT margin von -163.70%
- Nektar Therapeutics hat EBIT margin von -163.64%
- Nicholas hat EBIT margin von -162.88%
- SenSen Networks hat EBIT margin von -162.60%
- Kiadis Pharma N.V hat EBIT margin von -161.82%
- Clovis Oncology Inc hat EBIT margin von -161.75%
- co.don AG hat EBIT margin von -161.62%
- Noida Toll Bridge hat EBIT margin von -161.17%
- Xcel Brands Inc hat EBIT margin von -160.69%
- Durect Corp hat EBIT margin von -160.60%
- Petros Pharmaceuticals hat EBIT margin von -159.30%
- Xelpmoc Design and Tech hat EBIT margin von -159.13%